Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

33.74

-0.18 (-0.53%)

Jan 20, 2026, 12:14 PM EST - Market open

Viking Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	52.36	49.28	37.02	16.12	10.7	10.73	Upgrade
Research & Development	222.48	101.64	63.81	54.23	44.98	31.93	Upgrade
Operating Expenses	274.84	150.92	100.83	70.36	55.68	42.66	Upgrade
Operating Income	-274.84	-150.92	-100.83	-70.36	-55.68	-42.66	Upgrade
Interest Expense	-0.08	-0.09	-0.09	-0.06	-0.02	-0.11	Upgrade
Interest & Investment Income	37.51	40.94	15.02	1.59	0.7	3.23	Upgrade
Currency Exchange Gain (Loss)	-	-	-	-	0.01	-	Upgrade
EBT Excluding Unusual Items	-237.41	-110.08	-85.9	-68.83	-54.99	-39.54	Upgrade
Gain (Loss) on Sale of Investments	0.02	0.11	-	-0.04	-	0.04	Upgrade
Pretax Income	-237.39	-109.96	-85.9	-68.87	-54.99	-39.5	Upgrade
Net Income	-237.39	-109.96	-85.9	-68.87	-54.99	-39.5	Upgrade
Net Income to Common	-237.39	-109.96	-85.9	-68.87	-54.99	-39.5	Upgrade
Shares Outstanding (Basic)	112	109	94	77	77	73	Upgrade
Shares Outstanding (Diluted)	112	109	94	77	77	73	Upgrade
Shares Change (YoY)	5.48%	15.57%	22.79%	-0.47%	6.34%	0.89%	Upgrade
EPS (Basic)	-2.12	-1.01	-0.91	-0.90	-0.71	-0.54	Upgrade
EPS (Diluted)	-2.12	-1.01	-0.91	-0.90	-0.71	-0.54	Upgrade
EBIT	-274.84	-150.92	-100.83	-70.36	-55.68	-42.66	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q